Patents by Inventor Wah Yuen To

Wah Yuen To has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20230382983
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Application
    Filed: February 6, 2023
    Publication date: November 30, 2023
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • Complement factor D antagonist antibodies and conjugates thereof
    Patent number: 11584790
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: February 21, 2023
    Assignee: KODIAK SCIENCES INC.
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20210324063
    Abstract: Provided herein are anti-VEGF-A antibodies and antibody conjugates thereof. Some embodiments of the antibodies can be conjugated to a moiety, such as a HEMA-PC polymer. Some embodiments of the antibody conjugates can retain or enhance antibody activity. The antibody and conjugate thereof can be particularly useful for treating diabetic retinopathy. Further provided are methods for conjugation of a polymer to a protein such as an antibody, such as IgG1.
    Type: Application
    Filed: April 8, 2021
    Publication date: October 21, 2021
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang
  • Antibodies and conjugates thereof
    Patent number: 11066465
    Abstract: Provided herein are anti-VEGF-A antibodies and antibody conjugates thereof. Some embodiments of the antibodies can be conjugated to a moiety, such as a HEMA-PC polymer. Some embodiments of the antibody conjugates can retain or enhance antibody activity. The antibody and conjugate thereof can be particularly useful for treating diabetic retinopathy. Further provided are methods for conjugation of a polymer to a protein such as an antibody, such as IgG1.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: July 20, 2021
    Assignee: KODIAK SCIENCES INC.
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang
  • COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20180334496
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Application
    Filed: April 12, 2018
    Publication date: November 22, 2018
    Inventors: D. Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20170190766
    Abstract: Provided herein are anti-VEGF-A antibodies and antibody conjugates thereof. Some embodiments of the antibodies can be conjugated to a moiety, such as a HEMA-PC polymer. Some embodiments of the antibody conjugates can retain or enhance antibody activity. The antibody and conjugate thereof can be particularly useful for treating diabetic retinopathy. Further provided are methods for conjugation of a polymer to a protein such as an antibody, such as IgG1.
    Type: Application
    Filed: December 29, 2016
    Publication date: July 6, 2017
    Inventors: D. Victor Perlroth, Wah Yuen To, Hong Liang